Back
ImmuCell Corp. 10K Form
Buy
55
ICCC
ImmuCell Corp.
Last Price:
$6.30
Seasonality Move:
10.73%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-14 | 10Q | ICCC/ImmuCell Corp. Quarterly |
| 2023-11-13 | 10Q | ICCC/ImmuCell Corp. Quarterly |
| 2023-08-10 | 10Q | ICCC/ImmuCell Corp. Quarterly |
| 2023-05-11 | 10Q | ICCC/ImmuCell Corp. Quarterly |
| 2022-11-21 | 10Q | ICCC/ImmuCell Corp. Quarterly |
| 2022-08-11 | 10Q | ICCC/ImmuCell Corp. Quarterly |
Receive ICCC News And Ratings
See the #1 stock for the next 7 days that we like better than ICCC
ICCC Financial Statistics
Sales & Book Value
| Annual Sales: | $27.6M |
|---|---|
| Cash Flow: | $482.2K |
| Price / Cash Flow: | 47.45 |
| Annual Sales: | $3.29 |
| Price / Book: | 2.15 |
Profitability
| EPS (TTM): | -0.11370 |
|---|---|
| Net Income (TTM): | $-1M |
| Gross Margin: | $11.4M |
| Return on Equity: | -3.63% |
| Return on Assets: | -2.3% |
ImmuCell Corp. Earnings Forecast
Key ImmuCell Corp. Financial Ratios
-
The Gross Profit Margin over the past 37 years for ICCC is 41.40%.
-
The Selling, General & Administrative Expenses for ICCC have been equal to 24.43% of Gross Profit Margin.
-
The Research & Development expenses have been 11.00% of Revenue.
-
The Net Earning history of ICCC is -3.76% of Total Revenues.
-
Per Share Earnings over the last 37 years have been positive in 19 years.
ImmuCell Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ICCC |
| CUSIP: | 452525 |
| Website: | immucell.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.21 |
| Quick Ratio: | 1.61 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ICCC Technical Analysis vs Fundamental Analysis
Buy
55
ImmuCell Corp. (ICCC)
is a Buy
Is ImmuCell Corp. a Buy or a Sell?
-
ImmuCell Corp. stock is rated a BuyThe current ImmuCell Corp. [ICCC] share price is $6.44. The Score for ICCC is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.